These genes include those mutated in other cancer types and bound with HCV proteins (e.g. PIK3R1 and EP300), genes interfacing with alternative partner groups (e.g. YWHAZ), and genes manifesting both differential co-expression and differential expression (e.g. ESR1). This evidence concerns the gene PIK3R1 and cancer.